Rolley E Johnson

Summary

Publications

  1. ncbi request reprint Buprenorphine: how to use it right
    Rolley E Johnson
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Drive, Baltimore, MD 21224, USA
    Drug Alcohol Depend 70:S59-77. 2003
  2. ncbi request reprint Use of buprenorphine in pregnancy: patient management and effects on the neonate
    Rolley E Johnson
    Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA
    Drug Alcohol Depend 70:S87-101. 2003
  3. pmc Methadone, cocaine, opiates, and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomes
    Ana de Castro
    Chemical and Drug Metabolism Section, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland, USA
    Ther Drug Monit 33:443-52. 2011
  4. ncbi request reprint Umbilical cord monitoring of in utero drug exposure to buprenorphine and correlation with maternal dose and neonatal outcomes
    Marta Concheiro
    Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland 21224, USA
    J Anal Toxicol 34:498-505. 2010
  5. ncbi request reprint Transferring methadone-stabilized pregnant patients to buprenorphine using an immediate release morphine transition: an open-label exploratory study
    Hendree E Jones
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Am J Addict 15:61-70. 2006
  6. pmc Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrument
    D Andrew Tompkins
    Johns Hopkins University School of Medicine, Department of Psychiatry and Behavioral Sciences, Behavioral Pharmacology Research Unit, 5510 Nathan Shock Drive, Baltimore, MD 21224, USA
    Drug Alcohol Depend 105:154-9. 2009
  7. ncbi request reprint Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome
    Hendree E Jones
    The Department of Psychiatry and Behavioral Sciences, Johns Hopkins Bayview Medical Campus, Johns Hopkins University School of Medicine, D 3 East, 4940 Eastern Avenue, Baltimore, MD 21224, USA
    Drug Alcohol Depend 79:1-10. 2005
  8. pmc Methadone and metabolites in hair of methadone-assisted pregnant women and their infants
    Sarah K Himes
    Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA
    Ther Drug Monit 34:337-44. 2012
  9. ncbi request reprint Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence
    Lisa A Marsch
    Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Exp Clin Psychopharmacol 13:293-302. 2005
  10. doi request reprint Maternal methadone dose, placental methadone concentrations, and neonatal outcomes
    Ana de Castro
    Chemistry and Drug Metabolism, National Institute on Drug Abuse, NIH, Baltimore, MD 21224, USA
    Clin Chem 57:449-58. 2011

Collaborators

Detail Information

Publications22

  1. ncbi request reprint Buprenorphine: how to use it right
    Rolley E Johnson
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Drive, Baltimore, MD 21224, USA
    Drug Alcohol Depend 70:S59-77. 2003
    ....
  2. ncbi request reprint Use of buprenorphine in pregnancy: patient management and effects on the neonate
    Rolley E Johnson
    Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA
    Drug Alcohol Depend 70:S87-101. 2003
    ..From a review of the literature, buprenorphine appears to be safe and effective in both mother and infant with an NAS that may differ from methadone both qualitatively and quantitatively...
  3. pmc Methadone, cocaine, opiates, and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomes
    Ana de Castro
    Chemical and Drug Metabolism Section, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland, USA
    Ther Drug Monit 33:443-52. 2011
    ....
  4. ncbi request reprint Umbilical cord monitoring of in utero drug exposure to buprenorphine and correlation with maternal dose and neonatal outcomes
    Marta Concheiro
    Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland 21224, USA
    J Anal Toxicol 34:498-505. 2010
    ..Buprenorphine provided a controlled drug administration model for evaluating drug disposition in the maternal-fetal dyad...
  5. ncbi request reprint Transferring methadone-stabilized pregnant patients to buprenorphine using an immediate release morphine transition: an open-label exploratory study
    Hendree E Jones
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Am J Addict 15:61-70. 2006
    ..Withdrawal symptoms appeared during buprenorphine induction; however, these data suggest that the intensity of withdrawal symptoms may be lessened by the dose and frequency of buprenorphine administration...
  6. pmc Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrument
    D Andrew Tompkins
    Johns Hopkins University School of Medicine, Department of Psychiatry and Behavioral Sciences, Behavioral Pharmacology Research Unit, 5510 Nathan Shock Drive, Baltimore, MD 21224, USA
    Drug Alcohol Depend 105:154-9. 2009
    ..Though commonly used in clinical practice, it has not been systematically validated. The present study validated the COWS in comparison to the validated Clinical Institute Narcotic Assessment (CINA) scale...
  7. ncbi request reprint Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome
    Hendree E Jones
    The Department of Psychiatry and Behavioral Sciences, Johns Hopkins Bayview Medical Campus, Johns Hopkins University School of Medicine, D 3 East, 4940 Eastern Avenue, Baltimore, MD 21224, USA
    Drug Alcohol Depend 79:1-10. 2005
    ..25). Results suggest that buprenorphine is not inferior to methadone on outcome measures assessing NAS and maternal and neonatal safety when administered starting in the second trimester of pregnancy...
  8. pmc Methadone and metabolites in hair of methadone-assisted pregnant women and their infants
    Sarah K Himes
    Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA
    Ther Drug Monit 34:337-44. 2012
    ....
  9. ncbi request reprint Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence
    Lisa A Marsch
    Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Exp Clin Psychopharmacol 13:293-302. 2005
    ..We did not find any factors that would strongly guide selection of one medication over others...
  10. doi request reprint Maternal methadone dose, placental methadone concentrations, and neonatal outcomes
    Ana de Castro
    Chemistry and Drug Metabolism, National Institute on Drug Abuse, NIH, Baltimore, MD 21224, USA
    Clin Chem 57:449-58. 2011
    ....
  11. ncbi request reprint Buprenorphine and norbuprenorphine in hair of pregnant women and their infants after controlled buprenorphine administration
    Robert S Goodwin
    Chemistry and Drug Metabolism Section, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, MD 21224, USA
    Clin Chem 53:2136-43. 2007
    ..We hypothesized that there would be a relationship between the cumulative maternal dose of buprenorphine during pregnancy and the concentration of buprenorphine and norbuprenorphine in maternal and infant hair...
  12. pmc Maternal buprenorphine dose, placenta buprenorphine, and metabolite concentrations and neonatal outcomes
    Marta Concheiro
    Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, USA
    Ther Drug Monit 32:206-15. 2010
    ....
  13. pmc Urinary excretion of buprenorphine, norbuprenorphine, buprenorphine-glucuronide, and norbuprenorphine-glucuronide in pregnant women receiving buprenorphine maintenance treatment
    Sherri L Kacinko
    Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, NIH, Baltimore, MD, USA
    Clin Chem 55:1177-87. 2009
    ..We investigated BUP and metabolite disposition in urine from women maintained on BUP during the second and third trimesters of pregnancy and postpartum...
  14. pmc Excretion of methadone in sweat of pregnant women throughout gestation after controlled methadone administration
    Allan J Barnes
    Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA
    Ther Drug Monit 32:497-503. 2010
    ....
  15. doi request reprint Infant neurobehavior following prenatal exposure to methadone or buprenorphine: results from the neonatal intensive care unit network neurobehavioral scale
    Hendree E Jones
    Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA
    Subst Use Misuse 45:2244-57. 2010
    ..Results suggest the NNNS may detect subtle differences over time between both neonates prenatally exposed to methadone or buprenorphine and neonates pharmacologically treated or untreated for NAS...
  16. doi request reprint Confirmatory analysis of buprenorphine, norbuprenorphine, and glucuronide metabolites in plasma by LCMSMS. Application to umbilical cord plasma from buprenorphine-maintained pregnant women
    Marta Concheiro
    Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Biomedical Research Center BRC, 251 Bayview Boulevard, Suite 200, Room 05A721, Baltimore, MD 21224, USA
    J Chromatogr B Analyt Technol Biomed Life Sci 878:13-20. 2010
    ..5+/-0.8ng/mL) and BUP (0.4+/-0.2ng/mL). Although BUP biomarkers can be quantified in umbilical cord plasma in low ng/mL concentrations, the significance of these data as predictors of neonatal outcomes is currently unknown...
  17. ncbi request reprint Males and females differ in response to opioid agonist medications
    Hendree E Jones
    Department of Psychiatry and Behavioral Sciences, The Jhons Hopkins University School of Medicine, Baltimore, MD 21224, USA
    Am J Addict 14:223-33. 2005
    ..Within-subject change results indicate that all three medications benefit both sexes. Clinical trials should be designed to examine the impact of sex on outcomes...
  18. ncbi request reprint Safety and efficacy of L-tryptophan and behavioral incentives for treatment of cocaine dependence: a randomized clinical trial
    Hendree E Jones
    Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA
    Am J Addict 13:421-37. 2004
    ..This study also showed that contingent vouchers were effective in the novel experimental model of relapse prevention...
  19. ncbi request reprint Randomized controlled study transitioning opioid-dependent pregnant women from short-acting morphine to buprenorphine or methadone
    Hendree E Jones
    The Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA
    Drug Alcohol Depend 78:33-8. 2005
    ..Transitioning opioid-dependent pregnant women from IRM to methadone or buprenorphine during the second trimester of pregnancy can be conducted with similar comfort and safety...
  20. doi request reprint Dosing adjustments in postpartum patients maintained on buprenorphine or methadone
    Hendree E Jones
    From the Departments of Psychiatry and Behavioral Sciences HEJ, REJ, MT, Medicine DRJ, and Obstetrics and Gynecology LM, Johns Hopkins University School of Medicine, Baltimore, MD Reckitt Benckiser Pharmaceuticals Inc REJ, Richmond, VA and the Department of Psychology KEO, University of Maryland, College Park, College Park, MD
    J Addict Med 2:103-7. 2008
    ..Buprenorphine-maintained participants required dose changes postpartum only after they transferred to methadone. Regardless of type of medication, postpartum patients should be monitored for signs of overmedication...
  21. ncbi request reprint Buprenorphine: considerations for pain management
    Rolley E Johnson
    Department of Psychiatry and Behavioral Sciences, Behavioral Pharmacology Research Unit, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    J Pain Symptom Manage 29:297-326. 2005
    ..However, withdrawal symptoms appear to be mild to moderate in intensity compared with those of full mu agonists. Overdoses have primarily involved buprenorphine taken in combination with other central nervous system depressants...
  22. pmc Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence
    Ivan D Montoya
    Division of Treatment Research and Development and Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, Baltimore, MD 21224, USA
    Clin Pharmacol Ther 75:34-48. 2004
    ..Its efficacy for cocaine dependence is uncertain. This study evaluated buprenorphine for the treatment of concomitant cocaine and opiate dependence...